Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Sumida

Showing results (161-170 of 220) with videos related to

Pageof 22
Sort By:
Journal of Gastroenterology|February 25, 2015
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitisSumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, et al.
Hepatology (Baltimore, Md.)|July 23, 2015
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkersYoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 3, 2015
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitisSumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, et al.
Life (Basel, Switzerland)|March 6, 2021
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global MetabodemicYoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, et al.
Nutrients|September 9, 2022
Characterization of Nutrient Intake in Biopsy-Confirmed NAFLD PatientsYoshihiro Kamada, Hirokazu Takahashi, Yuji Ogawa, et al.
International Journal of Molecular Sciences|March 15, 2020
Antidiabetic Therapy in the Treatment of Nonalcoholic SteatohepatitisYoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, et al.
Journal of Gastroenterology|July 6, 2004
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in JapanMotoyoshi Yano, Hisao Hayashi, Kentaro Yoshioka, et al.
BMC Gastroenterology|February 21, 2012
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver diseaseMasato Yoneda, Shuhei Naka, Kazuhiko Nakano, et al.
Journal of Gastroenterology|November 28, 2012
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levelsMasato Yoneda, Kento Imajo, Yuichiro Eguchi, et al.
World Journal of Hepatology|December 16, 2015
Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matchingHideki Fujii, Takeshi Nishimura, Atsushi Umemura, et al.
Pageof 22

Showing results (161-170 of 220) with videos related to

Sort By:
Pageof 22
Journal of Gastroenterology|February 25, 2015
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitisSumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, et al.
Hepatology (Baltimore, Md.)|July 23, 2015
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkersYoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 3, 2015
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitisSumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, et al.
Life (Basel, Switzerland)|March 6, 2021
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global MetabodemicYoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, et al.
Nutrients|September 9, 2022
Characterization of Nutrient Intake in Biopsy-Confirmed NAFLD PatientsYoshihiro Kamada, Hirokazu Takahashi, Yuji Ogawa, et al.
International Journal of Molecular Sciences|March 15, 2020
Antidiabetic Therapy in the Treatment of Nonalcoholic SteatohepatitisYoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, et al.
Journal of Gastroenterology|July 6, 2004
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in JapanMotoyoshi Yano, Hisao Hayashi, Kentaro Yoshioka, et al.
BMC Gastroenterology|February 21, 2012
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver diseaseMasato Yoneda, Shuhei Naka, Kazuhiko Nakano, et al.
Journal of Gastroenterology|November 28, 2012
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levelsMasato Yoneda, Kento Imajo, Yuichiro Eguchi, et al.
World Journal of Hepatology|December 16, 2015
Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matchingHideki Fujii, Takeshi Nishimura, Atsushi Umemura, et al.
Pageof 22